Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-02-20 @ 6:46 PM
Study NCT ID:
NCT03371550
Status:
COMPLETED
Last Update Posted:
2017-12-13
First Post:
2017-11-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy
Sponsor:
Centre Antoine Lacassagne
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2004/07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None